Submission Details
| 510(k) Number | K231328 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 08, 2023 |
| Decision Date | August 19, 2023 |
| Days to Decision | 103 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K231328 is an FDA 510(k) clearance for the LUX-Dx II (M302); LUX-Dx II+ (M312), a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II — Special Controls, product code MXD), submitted by Boston Scientific Corp (Alternate Contact, US). The FDA issued a Cleared decision on August 19, 2023, 103 days after receiving the submission on May 8, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1025.
| 510(k) Number | K231328 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 08, 2023 |
| Decision Date | August 19, 2023 |
| Days to Decision | 103 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1025 |